Barclays’s Molecular Templates, Inc. MTEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-102
| Closed | -$4 | – | 5700 |
|
|
2024
Q4 | $4 | Sell |
102
-373
| -79% | -$216 | ﹤0.01% | 5239 |
|
|
2024
Q3 | $668 | Hold |
475
| – | – | ﹤0.01% | 5136 |
|
|
2024
Q2 | $546 | Buy |
475
+100
| +27% | +$148 | ﹤0.01% | 4707 |
|
|
2024
Q1 | $840 | Hold |
375
| – | – | ﹤0.01% | 4954 |
|
|
2023
Q4 | $1.4K | Buy |
+375
| New | +$1.96K | ﹤0.01% | 5094 |
|
|
2023
Q3 | – | Sell |
-375
| Closed | -$2.7K | – | 4790 |
|
|
2023
Q2 | $2.7K | Hold |
375
| – | – | ﹤0.01% | 4306 |
|
|
2023
Q1 | $2.14K | Hold |
375
| – | – | ﹤0.01% | 4886 |
|
|
2022
Q4 | $1.85K | Sell |
375
-84
| -18% | -$696 | ﹤0.01% | 5090 |
|
|
2022
Q3 | $5K | Sell |
459
-37
| -7% | -$465 | ﹤0.01% | 4519 |
|
|
2022
Q2 | $7K | Buy |
+496
| New | +$11.6K | ﹤0.01% | 4732 |
|
|
2021
Q3 | – | Sell |
-911
| Closed | -$107K | – | 5091 |
|
|
2021
Q2 | $107K | Sell |
911
-630
| -41% | -$82.5K | ﹤0.01% | 3823 |
|
|
2021
Q1 | $291K | Buy |
1,541
+971
| +170% | +$170K | ﹤0.01% | 3516 |
|
|
2020
Q4 | $80K | Sell |
570
-238
| -29% | -$35.2K | ﹤0.01% | 4225 |
|
|
2020
Q3 | $132K | Sell |
808
-81
| -9% | -$14.4K | ﹤0.01% | 4091 |
|
|
2020
Q2 | $184K | Buy |
889
+439
| +98% | +$102K | ﹤0.01% | 4126 |
|
|
2020
Q1 | $89K | Sell |
450
-686
| -60% | -$150K | ﹤0.01% | 4884 |
|
|
2019
Q4 | $238K | Buy |
1,136
+575
| +102% | +$82.6K | ﹤0.01% | 4907 |
|
|
2019
Q3 | $55K | Sell |
561
-171
| -23% | -$15.9K | ﹤0.01% | 5868 |
|
|
2019
Q2 | $92K | Buy |
732
+446
| +156% | +$48.5K | ﹤0.01% | 5755 |
|
|
2019
Q1 | $25K | Buy |
286
+260
| +1,000% | +$19.1K | ﹤0.01% | 6271 |
|
|
2018
Q4 | $1K | Sell |
26
-215
| -89% | -$15K | ﹤0.01% | 6849 |
|
|
2018
Q3 | $19K | Buy |
241
+197
| +448% | +$15.1K | ﹤0.01% | 6485 |
|
|
2018
Q2 | $3K | Sell |
44
-185
| -81% | -$20.9K | ﹤0.01% | 6802 |
|
|
2018
Q1 | $27K | Buy |
+229
| New | +$34.5K | ﹤0.01% | 6307 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7058 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6906 |
|
|
2016
Q3 | – | Sell |
-8
| Closed | -$1.1K | – | 6860 |
|
|
2016
Q2 | $1K | Buy |
+8
| New | +$573 | ﹤0.01% | 6192 |
|
|
2016
Q1 | – | Sell |
-189
| Closed | -$11.2K | – | 6521 |
|
|
2015
Q4 | $0 | Sell |
189
-18
| -9% | -$8.87K | ﹤0.01% | 6736 |
|
|
2015
Q3 | $136K | Buy |
207
+107
| +107% | +$76.1K | ﹤0.01% | 4412 |
|
|
2015
Q2 | $66K | Buy |
100
+50
| +100% | +$33K | ﹤0.01% | 4980 |
|
|
2015
Q1 | $33K | Sell |
50
-126
| -72% | -$83K | ﹤0.01% | 5568 |
|
|
2014
Q4 | $87K | Sell |
176
-165
| -48% | -$82.5K | ﹤0.01% | 5319 |
|
|
2014
Q3 | $170K | Sell |
341
-101
| -23% | -$69.9K | ﹤0.01% | 4890 |
|
|
2014
Q2 | $220K | Buy |
442
+177
| +67% | +$117K | ﹤0.01% | 4730 |
|
|
2014
Q1 | $175K | Buy |
265
+149
| +128% | +$121K | ﹤0.01% | 4907 |
|
|
2013
Q4 | $76K | Buy |
116
+105
| +955% | +$79.2K | ﹤0.01% | 5874 |
|
|
2013
Q3 | $7K | Sell |
11
-22
| -67% | -$18.1K | ﹤0.01% | 6909 |
|
|
2013
Q2 | $28K | Buy |
+33
| New | +$27.9K | ﹤0.01% | 6668 |
|
Barclays's MTEM Position: Q1 2025 in Review
Barclays sold out of Molecular Templates, Inc. (MTEM) in Q1 2025, closing a stake of 102 shares — an estimated $4 sold.
Barclays first reported a position in MTEM in Q2 2013 and held it in 36 quarters. The position peaked at $291K in Q1 2021. 0 funds tracked by Wall St. Rank hold MTEM as of Q1 2025.
- Barclays reported no remaining Molecular Templates, Inc. position as of Q1 2025 after selling out during the quarter.
- Barclays sold 102 Molecular Templates, Inc. shares in Q1 2025, an estimated $4.
- Barclays first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 36 quarters.
- Barclays's Molecular Templates, Inc. position peaked at $291K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2025.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.